West Branch Capital’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.8K Hold
75
﹤0.01% 199
2026
Q1
$15.8K Hold
75
﹤0.01% 196
2025
Q4
$15.4K Sell
75
-75
-50% -$14.1K ﹤0.01% 214
2025
Q3
$23.5K Hold
150
0.01% 194
2025
Q2
$25.2K Sell
150
-1
-0.7% -$148 0.01% 192
2025
Q1
$20.8K Hold
151
0.01% 219
2024
Q4
$17.9K Hold
151
0.01% 230
2024
Q3
$16.7K Buy
151
+1
+0.7% +$105 0.01% 238
2024
Q2
$14.7K Hold
150
0.01% 244
2024
Q1
$16.8K Hold
150
0.01% 236
2023
Q4
$15.1K Buy
150
+75
+100% +$7.44K 0.01% 249
2023
Q3
$6.51K Hold
75
﹤0.01% 313
2023
Q2
$7.09K Hold
75
﹤0.01% 309
2023
Q1
$5.66K Hold
75
﹤0.01% 342
2022
Q4
$5.76K Hold
75
﹤0.01% 327
2022
Q3
$5K Buy
+75
New +$4.75K ﹤0.01% 341

Other funds holding CAH

West Branch Capital's CAH Position: Q2 2026 in Review

West Branch Capital held its Cardinal Health (CAH) position steady in Q2 2026 at 75 shares worth $17.8K. The position accounts for ﹤0.01% of the portfolio, ranked #199.

West Branch Capital first reported a position in CAH in Q3 2022 and has held it in 16 quarters since. The position peaked at $25.2K in Q2 2025. 341 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • West Branch Capital held 75 shares of Cardinal Health worth $17.8K as of Q2 2026.
  • West Branch Capital left its Cardinal Health share count unchanged in Q2 2026.
  • Cardinal Health made up ﹤0.01% of West Branch Capital's portfolio in Q2 2026, its #199 holding.
  • West Branch Capital first reported a position in Cardinal Health in Q3 2022 and has held it in 16 quarters since.
  • West Branch Capital's Cardinal Health position peaked at $25.2K in Q2 2025.
  • 341 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on West Branch Capital's 13F filing for Q2 2026, filed 10 Jul 2026.